PART
IV:
SYMPTOMS
OF BEING
INTOXICATED
BY QUINOLONES
If you have taken a course of any
quinolone or fluoroquinolone antibiotic (Cipro, Levaquin, Floxin, etc¼) you have been chemically
poisoned. Depending on individual conditions, and the dosage and length of the
treatment, the intoxication will range from very mild and asymptomatic to very
severe and disabling.
In a minority of cases, the
patient notices the reaction immediately. In a vast number of cases, most
symptoms, or at least the most severe ones, emerge during the last stages of
the treatment, or weeks or months after the completion of the quinolone
treatment.
Sedentary people tend to notice
less adverse reactions because they do not use their body to full active
capacity. Taking into account that at least one third of QTS presentations are
predominately tendon-related or musculoskeletal, damage to their tendons,
cartilages and muscles remains unnoticed.
Almost everybody can take low
doses of quinolones without developing any symptoms of an adverse reaction (for
instance, 250 mg daily of cipro for two weeks). Many people can take a 7-day
course of a medium dosage of quinolone antibiotics (for instance, 750 mg daily
of cipro) without perceiving any adverse effects. For higher doses (for
instance two weeks of 1.000 mg of cipro), most people are also asymptomatic
during their first treatments (remember that the damage is cumulative). For
these latter doses, their cartilage, tendons, nerves and small veins and
arteries have been directly damaged but not enough to make them symptomatic.
That is the case of many sedentary people who deeply damage their joints as a
result of repeated but short courses of quinolones. But the fact remains
unknown to them since they are asymptomatic, and they do not use their joints
beyond the pain threshold. Later in life, it manifests as early osteoarthritis,
collagenous deterioration, or nervous system failures. In any case, this paper
is not intended for these people.
Look to the following medical
paper that seems to support the generalized toxicity caused by quinolones that
we have been postulating since long ago:
JEREMY NORMINGTON, DPT, IS DIRECTOR OF
PHYSICAL MEDICINE AND REHABILITATION AT
Another study by Koeger et al. looked at
tendons of asymptomatic fluoroquinolone users. Researchers observed
hypersignals that indicated common increased cellular activity (4-out-of-10) in
tendons of asymptomatic patients. This suggests that tendon metabolism is
altered in the absence of clinical signs.
Many of us were healthy young
athletes in perfect health with rock solid knees and hips prior to taking
quinolones, but now have become crippled persons, with our cartilages half
destroyed, our eyes barely functional, our bodies aching since several years
ago and our whole lives stolen from us by a medical class that now turns its
back on us.
For those that have developed
symptoms like the ones described later, first of all, they have to check if
they have ingested any quinolone antibiotics during the last three or four
years. The damage caused by the quinolone antibiotics becomes evident at a
point in time that ranges between the moment of the treatment itself from up to
eighteen months later. If your symptoms fit with any of the categories listed
later in this article, and you have taken fluoroquinolones in the past, then a
quinolone induced intoxication might well be the reason for all of your recent
physical problems. This report could help assist you in reaching a diagnosis.
This paper intentionally has a
non-medical quality. However, it is necessary that you become familiar with a few
technical facts regarding the floxing syndrome. Some are explained throughout
the report, when they are needed. A brief introduction to the general aspects
of an adverse drug reaction is included here.
The terms drug allergy, drug
reaction and some euphemisms (hypersensitivity, intolerance) are often used
interchangeably. If we take into account the immune response of the patient, a
drug allergy can be restricted to the reaction in which special antibodies of
the IgE type are massively released. This report does not cover allergic
reactions.
Drug reactions can be classified
as follows:
|
TABLE 7. TYPES OF DRUG REACTIONS |
|||
|
TYPE |
Specific |
Key feature |
Caused by quinolones |
|
IMMUNOLOGIC |
|||
|
Type I reaction |
IgE mediated |
Allergy |
Yes, rare |
|
Type II reaction |
Cytotoxic |
|
Yes, common |
|
Type III reaction |
Immune complex |
|
Yes, typical |
|
Type IV reaction |
Cell mediated, delayed |
|
Yes, frequent |
|
Specific T-cell activation |
|
|
? |
|
Other |
Chemical |
Unknown |
Yes, common |
|
NON-IMMUNOLOGIC |
|||
|
Primary pharmacological side effect |
Direct problem associated with the drug |
Yes |
|
|
Secondary pharmacological side effect |
Opportunistic health problem |
Yes |
|
|
Drug toxicity |
Toxicity to organs and systems |
Yes |
|
|
Interactions between drugs |
Like with all drugs |
Yes |
|
Some classifications have been
established in order to help discern among drug IMMUNE reactions:
|
TABLE 7-cont'd. TYPES OF IMMUNE REACTIONS |
|||
|
Immune reaction |
|||